Last reviewed · How we verify
NCT05227417
A Mobile Phone SMS Intervention to Increase Retention in HIV Care Among HIV-Positive MSM in Peru (WELTEL PERU)
NA trial testing SMS in Retention in Care in 208 participants. Completed in 31 December 2024.
12 May 2024
Quick facts
| Lead sponsor | Universidad Peruana Cayetano Heredia |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 208 |
| Start date | 31 January 2022 |
| Primary completion | 12 May 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across Peru |
Drugs / interventions tested
- SMS
Conditions studied
- Retention in Care — all drugs for Retention in Care →
- Hiv — all drugs for Hiv →
Sponsor
Universidad Peruana Cayetano Heredia — full company profile →
Who can join
18 and older, male only, with Retention in Care or Hiv. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
We will use a web-based system in order to deliver a text messaging-based intervention and assess the efficacy to increase retention in HIV care among HIV+ gay men in Peru.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05227417
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SMS
Trials testing the same drug.
- NCT06903091 — Efficacy of Text-messaging on Activity Limitation in People With Chronic Low Back · NA · not yet recruiting
- NCT05964842 — Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda · NA · completed
- NCT04332172 — Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy · NA · completed
- NCT05509270 — Efficacy of Communication Modalities for Promoting Flu Shots · NA · completed
- NCT05430451 — Simple Physical Exercise With Instant Messaging Support for Smoking Via "Quit to Win" Contest 2022 (QTW2022) · NA · unknown
Other recruiting trials for Retention in Care
Currently open trials in the same condition.
- NCT07425925 — Digital Peer-support-based Anti-HIV Stigma Intervention Among Adolescents Living With HIV in Ethiopia · NA · recruiting
- NCT06941974 — Partnering With Antenatal Navigators to Transform Health in Pregnancy · NA · recruiting
- NCT06859372 — Nurturing Care Family Navigator · NA · active not recruiting
- NCT06027671 — Structured Peer-delivered ART and Reentry Community Strategy · NA · recruiting
- NCT05973838 — Peer Recovery to Improve Polysubstance Use and Mobile Telemedicine Retention · NA · recruiting
Other Universidad Peruana Cayetano Heredia trials
Trials by the same sponsor.
- NCT06367361 — One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis · Phase 2 · not yet recruiting
- NCT06989502 — Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries · NA · not yet recruiting
- NCT06565507 — Oxfendazole in Mild Parenchymal Brain Cysticercosis · Phase 2, PHASE3 · not yet recruiting
- NCT05981378 — Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest · not yet recruiting
- NCT06500013 — WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05227417 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Peruana Cayetano Heredia
- Last refreshed: 30 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05227417.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing